Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term term follow-up. Found 9 abstracts

Ibrahim D, Smith MR, Varterasian M, Karanes C, Millenson M, Yeslow G, Pemberton P, Lai P, Abrams J, Al-Katib A. Phase II study of PEND chemotherapy in patients with refractory/relapsed Hodgkin lymphoma. Leukemia & lymphoma. 2004 Oct;45(10):2079-84.
Wiseman GA, Gordon LI, Multani PS, Witzig TE, Spies S, Bartlett NL, Schilder RJ, Murray JL, Saleh M, Allen RS, Grillo-Lopez AJ, White CA. Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial. Blood. 2002 Jun 15;99(12):4336-42.
Fowble B. Postmastectomy radiation in patients with one to three positive axillary nodes receiving adjuvant chemotherapy: An unresolved issue. Seminars in Radiation Oncology. 1999 Jul;9(3):230-40.
Green GA, Hanlon AL, Al-Saleem T, Hanks GE. A Gleason score of 7 predicts a worse outcome for prostate carcinoma patients treated with radiotherapy. Cancer. 1998 Sep;83(5):971-6.
Evans AA, Fine M, London WT. Spontaneous seroconversion in hepatitis B e antigen-positive chronic hepatitis B: Implications for interferon therapy. Journal of Infectious Diseases. 1997 Oct;176(4):845-50.
Ozols RF, Vermorken JB. Chemotherapy of advanced ovarian cancer: Current status and future directions. Seminars in Oncology. 1997 Feb;24(1):S1-S9.
Smith MR. Non-Hodgkin's lymphoma. Current Problems in Cancer. 1996 Jan;20(1):6-77.
Crilley P, Goldstein LJ. Peripheral-Blood Stem-Cell Transplant in Breast-Cancer. Seminars in Oncology. 1995 Jun;22(3):238-49.
Feitelson M, Lega L, Guo JH, Resti M, Rossi ME, Azzari C, Blumberg BS, Vierucci A. Pathogenesis of Posttransfusion Viral-Hepatitis in Children with Beta-Thalassemia. Hepatology (Baltimore, Md). 1994 Mar;19(3):558-68.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term term follow-up

term follow-up chemotherapy prognostic factors salvage therapy combined modality therapy epstein-barr-virus b virus-infection large-cell lymphoma i-131 PEND doxorubicin-cyclophosphamide hbsag-carrier children antigen bone-marrow-transplantation prednisone monoclonal-antibody cisplatin radical retropubic prostatectomy transplantation 2-chlorodeoxyadenosine lymph-nodes clinical autologous blood combination chemotherapy disease patients disease-free survival antigen antibody adjuvant chemotherapy chronic lymphocytic- therapy radiation- virus-infection susceptibility gene bone-marrow transplantation progression relapsed Hodgkin lymphoma phase-iii hbv infection randomized trial induction histiocytic lymphoma non-a colony- multivariate-analysis clinical-trial diffuse low-grade lymphoma combination first relapse stimulating factor breast-cancer patients prostate carcinoma controlled trial high-dose chemotherapy stem-cell transplantation circulating antibodies cancer gynecologic-oncology-group leukemia infections carcinoma Gleason grade autologous bone-marrow progenitor cells bone-marrow markers tumor-cells southwest-oncology-group treatment high-dose therapy premenopausal women randomized cyclophosphamide prostate alpha-interferon carboplatin alfa postoperative radiotherapy myelodysplastic syndrome adenocarcinoma regimen local-regional recurrence central-nervous-system specific antigen modified radical-mastectomy dexamethasone polymerase chain-reaction serologic markers x-gene product(s) childhood stage radiation therapy hepadnavirus clinical-trials
Last updated on Wednesday, February 05, 2020